MO HealthNet is continuing the state specific Preferred Drug List and Clinical Edit processes. The following is a listing of therapeutic classes that have been implemented. Please see the implementation schedule for proposed implementation dates for additional classes.

Issue Date Pharmacy Clinical Edit and PDL Description
06/05/09 15 Day Limitation
08/22/16 5-HT1 Agonist (Triptan) Therapy PDL
02/02/15 ACE Inhibitors PDL
02/02/15 ACE Inhibitors/Calcium Channel Blocker Combinations PDL
02/02/15 ACE Inhibitors Diuretic Combinations
03/07/16 ADHD Therapy
08/22/16 Alzheimer’s Agents (Cholinesterase Inhibitors) PDL
07/07/11 Ampyra
10/5/17 Amylin Analogs PDL
08/22/16 Antiemetics Agents PDL
02/02/15 Angiotensin Receptor Blocker Diuretic Combinations PDL
02/02/15 Angiotensin Receptor Blockers PDL
02/02/15 Anticoagulants PDL
10/05/17 AntiDiabetic Combinations: Oral and Injectable PDL
10/28/14 2nd Generation Antihistamines PDL
08/23/13 2nd Generation Antihistamines/Decongestant Combinations – PDL
10/05/17 Antihyperuricemic Agents PDL
01/12/18 Atypical Antipsychotics
10/28/14 Beta Adrenergic Agents Long Acting PDL
10/28/14 Beta Adrenergic Agents Short Acting PDL
10/28/14 Beta Adrenergic Agents/Nebulized PDL
02/02/15 Beta Adrenergic Blockers- PDL
10/31/17 BiDil® Tablets Clinical Edit
10/05/17 Bile Salts Agents PDL
10/05/17 Bone Deossification Suppression Agents PDL
09/01/17 Botulinum Toxin Clinical Edit
10/05/17 BPH Agents PDL (formerly Androgen Hormone Inhibitors)
07/05/11 Butorphanol
02/02/15 Calcium Channel Blockers (DHP) PDL
02/02/15 Calcium Channel Blockers (nonDHP) PDL
02/02/15 Calcium Channel Blockers/ARBS PDL
10/05/17 Cephalosporin Antibiotics – Oral PDL
10/28/14 COPD Agents PDL
07/01/13 Cough and Cold PDL
08/22/16 COX-2 Inhibitors PDL
10/05/17 Cryopyrin-Associated Periodic Syndrome (CAPS) Agents PDL
02/02/15 Direct Renin Inhibitors PDL
11/13/03 Dolgic LQ® (Acetaminophen/Butalbital/Caffeine)
10/05/17 DPP-IV Inhibitors PDL
10/05/17 Electrolyte Depleters PDL
05/16/07 Emsam®
01/19/06 Equetro®
08/01/17 Exondys 51® Clinical Edit
08/22/16 Fibromyalgia Agents
10/05/17 FluorQuinolones PDL
07/28/03 Forteo® (teriparatide injection / Parathyroid Hormone)
10/05/17 Gastrointestinal(GI) Antibiotics – Oral PDL
10/05/17 GLP-1 Receptor Agonists PDL
10/05/17 Growth Hormones PDL
07/07/03 H2 Antagonists
10/05/17 Hematopoietic Agents PDL
11/01/17 Hep C (HCV) Therapy
10/28/14 Herpes Antivirals PDL
03/05/15 HMG Co-A reductase inhibitors (statins) PDL
02/02/15 Homozygous Familial Hypercholesterolemia
12/11/03 H-Pylori Therapy
04/23/13 Human Papillomavirus Vaccines
10/28/14 Inhaled Corticosteroids PDL
10/05/17 Insulins Long Acting PDL
10/05/17 Insulins Mix PDL
10/05/17 Insulins PDL
10/05/17 Insulins Rapid Acting PDL
10/28/14 Intranasal Antihistamines PDL
10/28/14 Intranasal Steroids PDL
10/05/17 Intravaginal Antibiotics PDL
11/13/03 Klonopin Wafer® (clonazepam)
10/28/14 Leukotriene PDL
10/05/17 Macrolides - Adult PDL
10/05/17 Macrolides - Pediatric PDL
08/25/10 Megestrol Acetate
10/05/17 Methotrexate Oral and Injectable (NEW) PDL
10/05/17 Multiple Sclerosis Agents PDL
08/22/16 Narcotics, Long Acting PDL
03/05/14 Narcolepsy Inhibitors
05/22/15 Neuropathic Pain Agents
02/02/15 Niacin Preparations PDL
08/22/16 Non-Ergot Dopamine Receptor Agonists PDL
01/26/12 Non-Oral Contraceptives Fiscal Edit
02/07/13 Non-Sedating Antihistamines PDL
08/22/16 NSAID Agents PDL
08/24/10 NSAID Step Therapy Edit
05/03/07 Nubain®
05/23/13 Onfi (clobazam)
10/28/14 Onychomycosis Antifungal Agents PDL
10/28/14 Ophthalmic Antihistamines PDL
10/28/14 Ophthalmic Mast Cell Stabilizers PDL
10/28/14 Ophthalmic NSAIDs PDL
10/28/14 Ophthalmic Prostaglandin Agonists PDL
10/28/14 Ophthalmic Quinolones PDL
11/06/17 Opiate Dependence Agents
03/01/18 Opioids, Short Acting Clinical Edits
03/01/18 Opioids, Combination Short-Acting Clinical Edit
10/05/17 Oral AntiDiabetic: Alpha - Glucosidase Inhibitors PDL
10/05/17 Oral AntiDiabetic: Biguanides PDL
10/05/17 Oral AntiDiabetic: Meglintinides PDL
10/05/17 Oral AntiDiabetic: Sulfonylureas 2nd Generation PDL
10/05/17 Oral AntiDiabetic: Thiazolidinediones PDL
10/28/14 Otic Quinolones PDL
01/31/05 Oxandrin®
10/28/14 Pancreatic Enzyme Agents PDL
10/05/17 Penicillins (NEW) PDL
09/26/05 Prostin VR® Pediatric
02/02/15 Proton Pump Inhibitor PDL
11/12/10 Psychotropic Medications Polypharmacy
02/02/15 Pulmonary Hypertension Agents PDL
02/02/15 Pulmonary Hypertension Agents (Oral) PDL
07/07/11 Ranexa®
01/12/05 Raniclor™
12/23/04 Raptiva
08/02/17 Respiratory Monoclonal Antibodies Clinical Edit
10/12/16 Ribavirins PDL
08/22/16 Sedative Hypnotics PDL
12/08/10 Selective Serotonin Reuptake Inhibitor (SSRI)
10/28/14 Self Injecting Epinephrine Agents
07/07/11 Selzentry® (Maraviroc)
07/03/12 Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
08/22/16 Skeletal Muscle Relaxants
10/05/17 Sodium - Glucose Co - Transporter 2 (SGLT2) PDL
08/01/17 Spinraza® Clinical Edit
09/16/10 Synagis (palivizumab)
10/05/17 Targeted Immune Modulators (Formerly Biologics - DMARDs) PDL
10/05/17 Tetracyclines PDL
07/07/03 Thalomid (thalidomide)
10/28/14 Topical Agents for Psoriasis PDL
10/28/14 Topical Androgenic Agents
12/02/14 Topical Antifungal Agents
10/28/14 Topical Antiparasitics Agents
10/28/14 Topical Antiviral Agents
10/28/14 Topical Benzoyl Peroxide/Clindamycin Combination
05/27/16 Topical Immunomodulators PDL
10/28/14 Topical Retinoids PDL
10/28/14 Topical Steroids PDL
08/22/16 Tramadol-like Agents PDL
07/14/16 Transmucosal Immediate-Release Fentanyl (TIRF) Clinical Edit
01/16/04 Tricyclic Antidepressant Coordination of Care
02/02/15 TriGlyceride Lower Agents PDL
10/28/14 Ulcerative Colitis Oral Agents PDL
10/28/14 Ulcerative Colitis-Rectal PDL
10/05/17 Urinary Tract Antispasmodics PDL
03/07/03 Voriconazole (Vfend) / Antifungal
11/13/03 Xanax XR® (Alprazolam)
11/13/03 Zometa® (zoledronic acid)
07/03/12 Zostavax Injection